Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma

World Journal of Surgery

Volumn 37, Issue 4, 2013, Pages 820-828

  Kaibori, Masaki ^a   Kubo, Shoji ^b   Nagano, Hiroaki ^c   Hayashi, Michihiro ^d   Haji, Seiji ^e   Nakai, Takuya ^e   Ishizaki, Morihiko ^a   Matsui, Kosuke ^a   Uenishi, Takahiro ^b   Takemura, Shigekazu ^b   Wada, Hiroshi ^c   Marubashi, Shigeru ^c   Komeda, Koji ^d   Hirokawa, Fumitoshi ^d   Nakata, Yasuyuki ^e   Uchiyama, Kazuhisa ^d   Kwon, A Hon ^a  

^a KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

^e KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; EVALUATION; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84879694599     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-1902-3     Document Type: Article

References (45)

1. Bosch X, Ribes J, Borras J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19:271-285
2. Taylor-Robinson SD, Foster GR, Arora S et al (1997) Increase in primary liver cancer in the UK 1979-94. Lancet 350:1142-1143
3. EI-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750
4. Kotoh K, Sakai H, Sakamoto S et al (1994) The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol 89:194-198
5. Seki T, Wakabayashi M, Nakagawa T et al (1994) Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 74:817-825
6. Chen MS, Li JO, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321-328
7. Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10-24
8. Nagasue N, Uchida M, Makino Y et al (1993) Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 105:488-494
9. Shirabe K, Shimada M, Kajiyama K et al (1998) Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection. Cancer 83:2312-2316
10. Poon RT, Ng IO, Fan ST et al (2001) Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatotocellular carcinoma: a study of a prospective cohort. J Clin Oncol 19:3037-3044
11. Shimada K, Sano T, Sakamoto Y et al (2005) A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer 104:1939-1947
12. Fukuda S, Itamoto T, Amano H et al (2007) Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy. World J Surg 31:345-352
13. Strasberg SM, Belghiti J, Clavn P-A et al (2000) The Brisbane 2000 terminology of liver anatomy and resection. Terminology committee of the international hepato-pancreato-biliary association. HPB 2:333-339
14. Couinaud C (ed) (1957) Le Foie: Etudes Anatomiques et Chirurgicale. Masson, Paris
15. Kaibori M, Matsui Y, Hijikawa T et al (2006) Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery 139:385-394
16. Sobin LH, Wittekind C (eds) (1997) TNM classification of malignant tumors, 5th edn. Wiley, New York
17. Kubo S, Tsukamoto T, Hirohashi K et al (2003) Appropriate surgical management of small hepatocellular carcinomas in patients infected with hepatitis C virus. World J Surg 27:437-442
18. Yamamoto J, Kosuge T, Takayama T et al (1996) Recurrence of hepatocellular carcinoma after surgery. Br J Surg 83:1219-1222
19. Poon RT, Fan ST, Lo CM et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373-382
20. Poon RT, Fan ST, Wong J et al (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10-24
21. Chen WT, Chau GY, Lui WY et al (2004) Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol 30:414-420
22. Poon RT, Fan ST, Lo CM et al (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long term results of treatment and prognostic factors. Ann Surg 229:216-222
23. Lee PH, Lin WJ, Tsang YM et al (1995) Clinical management of recurrent hepatocellular carcinoma. Ann Surg 222:670-676
24. Shimada M, Takenaka K, Taguchi K et al (1998) Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227:80-85
25. Kosuge T, Makuuchi M, Takayama T et al (1993) Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 40:328-332
26. Okada S, Shimada K, Yamamoto J et al (1994) Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 106:1618-1624
27. Ryu M, Shimamura Y, Kinoshita T et al (1997) Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 27:252-257
28. Zhou XD, Tang ZY, Yu YQ et al (1994) Recurrence after resection of alpha-fetoprotein-positive hepatocellular carcinoma. J Cancer Res Clin Oncol 120:369-373
29. Moriyama M, Matsumura H, Aoki H et al (2003) Long-term outcome, with monitoring of platelet counts, in patients with chronic hepatitis C and liver cirrhosis after interferon therapy. Intervirology 46:296-307
30. Imai Y, Kawata S, Tamura S et al (1998) Relation of interferon therapy and hepatocellular carcinonma in patients with chronic hepatitis C. Osaka hepatocellular carcinoma prevention study group. Ann Intern Med 129:94-99
31. Takano S, Yokosuka O, Imazeki F et al (1995) Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21:650-655
32. Yoshida H, Shiratori Y, Moriyama M et al (1999) Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan IHIT Study Group. Ann Intern Med 131:174-181
33. Poynard T, Bedossa P, Opolon P et al (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINVIR and DOSVIRC groups. Lancet 349:825-832
34. Shibata M, Morizane T, Uchida T et al (1998) Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet 351:1773-1777
35. Tarao K, Ohkawa S, Shimizu A et al (1994) Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer 73:1149-1154
36. Schmidt KG, Rasmussen JW, Bekker C et al (1985) Kinetics and in vivo distribution of 111-in labeled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopenia. Scand J Haematol 34:39-46
37. Peck-Radosavljevic M, Zacher J, Meng YG et al (1997) Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 27:127-131
38. Kawasaki T, Takeshita A, Souda K et al (1999) Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol 94:1918-1922
39. Grober D, Giuliani D, Leevy CM et al (1984) Platelet associated IgG in hepatitis and cirrhosis. J Clin Immunol 4:109-113
40. Nagamine T, Ohtuka T, Takehara K et al (1996) Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 24:135-140
41. Lu SN, Wang JH, Liu SL et al (2006) Thrombocytopenia as surrogate for cirrhosis and a marker for the identification of patients at high risk for hepatocellular carcinoma. Cancer 107:2212-2222
42. Kubo S, Tanaka H, Shuto T et al (2004) Correlation between low platelet count and multicentricity of hepatocellular carcinoma in patients with chronic hepatitis C. Hepatol Res 4:221-225
43. Lok AS, Seeff LB, Morgan TR et al (2009) Incidence of hepatocellular carcinoma and associated risk factors in hepatitis-C-related advanced liver disease. Gastroenterology 136:138-148
44. Kobayashi M, Ikeda K, Kawamura Y et al (2009) High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma. Cancer 115:571-580
45. Minagawa M, Makuuchi M, Takayama T et al (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238:703-710